Medtronic annual ebitda margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Medtronic EBITDA Margin Growth & History (MDT)
Medtronic's ebitda margin was 25.92% for fiscal 2026.
View full Medtronic company overviewMedtronic annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-04-24 | 25.92% | −0.37 pp |
| 2025 | 2025-04-25 | 26.29% | +2.21 pp |
| 2024 | 2024-04-26 | 24.07% | −2.13 pp |
| 2023 | 2023-04-28 | 26.20% | −0.49 pp |
| 2022 | 2022-04-29 | 26.70% | +2.84 pp |
| 2021 | 2021-04-30 | 23.86% | −1.92 pp |
| 2020 | 2020-04-24 | 25.78% | −3.43 pp |
| 2019 | 2019-04-26 | 29.21% | −1.78 pp |
| 2018 | 2018-04-27 | 31.00% | +3.06 pp |
| 2017 | 2017-04-28 | 27.94% | −0.44 pp |
| 2016 | 2016-04-29 | 28.37% | +3.34 pp |
| 2015 | 2015-04-24 | 25.03% | −2.39 pp |
| 2014 | 2014-04-25 | 27.42% | −4.05 pp |
| 2013 | 2013-04-26 | 31.47% | — |
Medtronic quarterly ebitda margin
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-07-31 | 25.55% | −0.01 pp |
| Q4 2026 | 2026-04-24 | 26.39% | +0.89 pp |
| Q3 2026 | 2026-01-31 | 25.88% | −2.21 pp |
| Q3 2026 | 2026-01-23 | 24.54% | −3.56 pp |
| Q2 2026 | 2025-10-24 | 27.13% | +0.11 pp |
| Q1 2026 | 2025-07-25 | 25.57% | +1.05 pp |
| Q4 2025 | 2025-04-25 | 25.50% | +5.62 pp |
| Q3 2025 | 2025-01-24 | 28.10% | +1.74 pp |
| Q2 2025 | 2024-10-25 | 27.01% | +1.81 pp |
| Q1 2025 | 2024-07-26 | 24.51% | −0.68 pp |
| Q4 2024 | 2024-04-26 | 19.87% | −6.38 pp |
| Q3 2024 | 2024-01-26 | 26.36% | −0.45 pp |
| Q2 2024 | 2023-10-27 | 25.20% | −2.16 pp |
| Q1 2024 | 2023-07-28 | 25.19% | +0.86 pp |
| Q4 2023 | 2023-04-28 | 26.25% | −2.91 pp |
| Q3 2023 | 2023-01-27 | 26.80% | −3.22 pp |
| Q2 2023 | 2022-10-28 | 27.36% | −1.18 pp |
| Q1 2023 | 2022-07-29 | 24.33% | +5.17 pp |
| Q4 2022 | 2022-04-29 | 29.16% | +1.22 pp |
| Q3 2022 | 2022-01-28 | 30.03% | +4.88 pp |
| Q2 2022 | 2021-10-29 | 28.53% | +7.60 pp |
| Q1 2022 | 2021-07-30 | 19.16% | −1.47 pp |
| Q4 2021 | 2021-04-30 | 27.94% | +11.47 pp |
| Q3 2021 | 2021-01-29 | 25.14% | −4.69 pp |
| Q2 2021 | 2020-10-30 | 20.94% | −5.30 pp |
| Q1 2021 | 2020-07-31 | 20.62% | −7.96 pp |
| Q4 2020 | 2020-04-24 | 16.47% | −15.60 pp |
| Q3 2020 | 2020-01-24 | 29.83% | +0.45 pp |
| Q2 2020 | 2019-10-25 | 26.24% | −3.10 pp |
| Q1 2020 | 2019-07-26 | 28.59% | +2.83 pp |
| Q4 2019 | 2019-04-26 | 32.08% | +0.25 pp |
| Q3 2019 | 2019-01-25 | 29.38% | +0.85 pp |
| Q2 2019 | 2018-10-26 | 29.34% | −7.14 pp |
| Q1 2019 | 2018-07-27 | 25.76% | −1.55 pp |
| Q4 2018 | 2018-04-27 | 31.83% | +1.48 pp |
| Q3 2018 | 2018-01-26 | 28.52% | +2.75 pp |
| Q2 2018 | 2017-10-27 | 36.48% | +7.66 pp |
| Q1 2018 | 2017-07-28 | 27.31% | +0.74 pp |
| Q4 2017 | 2017-04-28 | 30.34% | +0.17 pp |
| Q3 2017 | 2017-01-27 | 25.77% | −4.08 pp |
| Q2 2017 | 2016-10-28 | 28.82% | +0.54 pp |
| Q1 2017 | 2016-07-29 | 26.57% | +1.38 pp |
| Q4 2016 | 2016-04-29 | 30.17% | +15.79 pp |
| Q3 2016 | 2016-01-29 | 29.85% | −4.45 pp |
| Q2 2016 | 2015-10-30 | 28.28% | −0.08 pp |
| Q1 2016 | 2015-07-31 | 25.19% | −5.31 pp |
| Q4 2015 | 2015-04-24 | 14.38% | — |
| Q3 2015 | 2015-01-23 | 34.30% | — |
| Q2 2015 | 2014-10-24 | 28.36% | — |
| Q1 2015 | 2014-07-25 | 30.49% | — |
Medtronic ebitda margin trends
Over the last five fiscal years, Medtronic's ebitda margin increased from 23.86% to 25.92%, a change of +2.06 percentage points. The latest reported quarter, Q1 2027, shows 25.55%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic gains cardiac-software clearances across two ablation platforms
Medtronic ($MDT) obtained FDA clearance and a European CE mark for its latest Affera Prism-2 cardiac mapping software, alongside a CE mark for the PulseSelect ProxBox adapter and Proximity Indicator software. The Affera upgrade adds tools f ...
Medtronic’s GI Genius system shows gains in large clinical-practice study
Cosmo reported new results for GI Genius, the AI-assisted endoscopy system it develops and Medtronic ($MDT) commercializes. The cluster-randomized quality-improvement study covered more than 334,000 colonoscopies across 139 US Veterans Heal ...
Medtronic wins FDA clearance for LigaSure instrument on Hugo robot
Medtronic ($MDT) received FDA clearance for the LigaSure RAS Maryland jaw instrument for its Hugo robotic-assisted surgery system. The instrument brings the company’s vessel-sealing technology to the robotic platform and is designed to seal ...
Medtronic launches MiniMed share-exchange offer
Medtronic ($MDT) launched an exchange offer to split off at least 80.1% of MiniMed ($MMED), its former diabetes business. Investors can voluntarily exchange Medtronic shares for MiniMed stock at a 7% discount, subject to a cap of 4.5939 Min ...
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...
